Viewing Study NCT00492050

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:53 PM
Ignite Modification Date: 2026-03-09 @ 1:59 AM
Study NCT ID: NCT00492050
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-02
First Post: 2007-06-26
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Waldenstrom's Macroglobulinemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Waldenstrom's Macroglobulinemia View
None Macroglobulinemic Lymphoma View
None Stem Cell Collection View
None Bortezomib View
None LDP-341 View
None MLN341 View
None PS-341 View
None Velcade View
None Rituximab View
None Rituxan View